Page last updated: 2024-12-05

indoxyl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Indoxyl acetate is a synthetic compound that has been studied for its potential to modulate the activity of certain enzymes, particularly those involved in the metabolism of drugs and other xenobiotics. It is synthesized through a series of chemical reactions, typically starting with indole and involving the use of acetic anhydride. Indoxyl acetate is known to inhibit the activity of enzymes such as carboxylesterases, which play a role in the detoxification of various compounds. This inhibitory effect has led to interest in its potential use as a probe for studying enzyme activity and for its potential therapeutic applications. For example, it has been investigated as a potential treatment for certain types of cancer. However, the safety and efficacy of indoxyl acetate in humans have not been fully established, and further research is needed before it can be considered for clinical use. Indoxyl acetate is also used as a model substrate in research studies that investigate the mechanisms of enzyme catalysis and inhibition.'

Cross-References

ID SourceID
PubMed CID11841
CHEMBL ID2074590
CHEBI ID169991
SCHEMBL ID3174139
SCHEMBL ID15553
MeSH IDM0151874

Synonyms (52)

Synonym
1h-indol-3-ol, 3-acetate
5-21-03-00006 (beilstein handbook reference)
indoxylacetate
einecs 210-154-2
3-indoxyl acetate
brn 0143086
nsc 13964
EN300-24658
CHEBI:169991
indole, 3-acetato-
indoxyl acetate
1h-indol-3-ol, acetate (ester)
acetic acid, 3-indolyl ester
608-08-2
nsc-13964
nsc13964
indoxyl-o-acetate
3-acetoxyindole
indol-3-ol, acetate (ester)
1h-indol-3-yl acetate
STK372207
indoxyl acetate, >=95% (gc)
3-indoxyl-3-acetate
I-5600
A0068
3-indolyl acetate
F2130-0060
AKOS001281841
A832894
bdbm50420240
FT-0615876
AM20040838
AB01158
indole acetate
CHEMBL2074590 ,
3-acetoxyindol
SCHEMBL3174139
SCHEMBL15553
DTXSID6060559
1h-indol-3-yl acetate #
1h-indol-3-ol, acetate
indol-3-ol, acetate
acetic acid 1h-indol-3-yl ester
mfcd00014561
VU0490361-1
1-(4-benzyloxyphenyl)piperazine
SY059874
CS-12497
CS-0142563
3AF7Z8794Q
Z199464144
HY-137884

Research Excerpts

Overview

Indoxyl acetate hydrolysis is a rapid, inexpensive differential test. It can be performed easily to help identify campylobacter.

ExcerptReferenceRelevance
"Indoxyl acetate hydrolysis is a rapid, inexpensive differential test which can be performed easily to help identify campylobacter. "( Evaluation of the indoxyl acetate hydrolysis test for the differentiation of Campylobacters.
Borczyk, A; Hodge, DS; Wat, LL, 1990
)
2.06
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
indolesAny compound containing an indole skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier family 22 member 6Homo sapiens (human)IC50 (µMol)83.00000.27004.53069.9000AID682036
Solute carrier family 22 member 8Homo sapiens (human)Ki491.00000.04004.22979.0000AID679676
Solute carrier family 22 member 8Rattus norvegicus (Norway rat)Ki582.00003.09005.54009.1000AID679632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier family 22 member 6Homo sapiens (human)Km14.00000.42004.61839.3000AID678998
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (14)

Processvia Protein(s)Taxonomy
monoatomic anion transportSolute carrier family 22 member 6Homo sapiens (human)
response to organic cyclic compoundSolute carrier family 22 member 6Homo sapiens (human)
inorganic anion transportSolute carrier family 22 member 6Homo sapiens (human)
organic anion transportSolute carrier family 22 member 6Homo sapiens (human)
prostaglandin transportSolute carrier family 22 member 6Homo sapiens (human)
alpha-ketoglutarate transportSolute carrier family 22 member 6Homo sapiens (human)
xenobiotic transportSolute carrier family 22 member 6Homo sapiens (human)
sodium-independent organic anion transportSolute carrier family 22 member 6Homo sapiens (human)
transmembrane transportSolute carrier family 22 member 6Homo sapiens (human)
metanephric proximal tubule developmentSolute carrier family 22 member 6Homo sapiens (human)
renal tubular secretionSolute carrier family 22 member 6Homo sapiens (human)
monoatomic ion transportSolute carrier family 22 member 8Homo sapiens (human)
response to toxic substanceSolute carrier family 22 member 8Homo sapiens (human)
inorganic anion transportSolute carrier family 22 member 8Homo sapiens (human)
prostaglandin transportSolute carrier family 22 member 8Homo sapiens (human)
xenobiotic transportSolute carrier family 22 member 8Homo sapiens (human)
transmembrane transportSolute carrier family 22 member 8Homo sapiens (human)
transport across blood-brain barrierSolute carrier family 22 member 8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (11)

Processvia Protein(s)Taxonomy
solute:inorganic anion antiporter activitySolute carrier family 22 member 6Homo sapiens (human)
protein bindingSolute carrier family 22 member 6Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier family 22 member 6Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier family 22 member 6Homo sapiens (human)
alpha-ketoglutarate transmembrane transporter activitySolute carrier family 22 member 6Homo sapiens (human)
antiporter activitySolute carrier family 22 member 6Homo sapiens (human)
transmembrane transporter activitySolute carrier family 22 member 6Homo sapiens (human)
chloride ion bindingSolute carrier family 22 member 6Homo sapiens (human)
identical protein bindingSolute carrier family 22 member 6Homo sapiens (human)
xenobiotic transmembrane transporter activitySolute carrier family 22 member 6Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier family 22 member 6Homo sapiens (human)
solute:inorganic anion antiporter activitySolute carrier family 22 member 8Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
xenobiotic transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
plasma membraneSolute carrier family 22 member 6Homo sapiens (human)
caveolaSolute carrier family 22 member 6Homo sapiens (human)
basal plasma membraneSolute carrier family 22 member 6Homo sapiens (human)
basolateral plasma membraneSolute carrier family 22 member 6Homo sapiens (human)
extracellular exosomeSolute carrier family 22 member 6Homo sapiens (human)
protein-containing complexSolute carrier family 22 member 6Homo sapiens (human)
plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
basolateral plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
apical plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
extracellular exosomeSolute carrier family 22 member 8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID682036TP_TRANSPORTER: inhibition of PAH uptake in OAT-expressing OK cells2002British journal of pharmacology, Jan, Volume: 135, Issue:2
Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake.
AID678998TP_TRANSPORTER: uptake in OAT1-expressing HEK293 cell2004Kidney international, Jan, Volume: 65, Issue:1
Characterization of uremic toxin transport by organic anion transporters in the kidney.
AID679676TP_TRANSPORTER: inhibition of benzylpenicillin uptake in OAT3-expressing HEK293 cells2004Kidney international, Jan, Volume: 65, Issue:1
Characterization of uremic toxin transport by organic anion transporters in the kidney.
AID679632TP_TRANSPORTER: inhibition of benzylpenicillin uptake in Oat3-expressing HEK293 cells2004Kidney international, Jan, Volume: 65, Issue:1
Characterization of uremic toxin transport by organic anion transporters in the kidney.
AID681393TP_TRANSPORTER: inhibition of Indoxyl sulfate uptake (indoxyl sulfate: 2 uM, Indoleacetic acid: 1000 uM) in Xenopus laevis oocytes2002Kidney international, May, Volume: 61, Issue:5
Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (24.00)18.7374
1990's4 (16.00)18.2507
2000's6 (24.00)29.6817
2010's6 (24.00)24.3611
2020's3 (12.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.70 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index35.22 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]